These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26755834)
41. Reversal by suramin of neuromuscular block produced by pancuronium in the anaesthetized rat. Henning RH; Nelemans A; Houwertjes M; Agoston S Br J Pharmacol; 1993 Mar; 108(3):717-20. PubMed ID: 8467359 [TBL] [Abstract][Full Text] [Related]
42. Interactions of diisopropyl phenol (ICI 35868) with suxamethonium, vecuronium and pancuronium in vitro. Fragen RJ; Booij LH; van der Pol F; Robertson EN; Crul JF Br J Anaesth; 1983 May; 55(5):433-6. PubMed ID: 6133527 [TBL] [Abstract][Full Text] [Related]
43. The neuromuscular blocking effect of trimetaphan alone and in combination with different non-depolarizing muscle relaxants in the rat. Pollard BJ; van der Spek AF J Pharm Pharmacol; 1987 Nov; 39(11):896-9. PubMed ID: 2892913 [TBL] [Abstract][Full Text] [Related]
44. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Donati F; Antzaka C; Bevan DR Anesthesiology; 1986 Jul; 65(1):1-5. PubMed ID: 3729027 [TBL] [Abstract][Full Text] [Related]
45. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Bowman WC; Rodger IW; Houston J; Marshall RJ; McIndewar I Anesthesiology; 1988 Jul; 69(1):57-62. PubMed ID: 2898902 [TBL] [Abstract][Full Text] [Related]
46. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block. Whalley DG; Lewis B; Bedocs NM Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941 [TBL] [Abstract][Full Text] [Related]
47. [A comparative study of atracurium, vecuronium and pancuronium using the rat phrenic nerve diaphragm preparation]. Fukushima K; Aoki T; Ishikawa J Masui; 1985 Jan; 34(1):66-70. PubMed ID: 2860258 [No Abstract] [Full Text] [Related]
48. The effect of temperature on the amplitude distributions of miniature endplate potentials in the mouse diaphragm. Carlson CG; Kriebel ME; Muniak CG Neuroscience; 1982 Oct; 7(10):2537-49. PubMed ID: 7177386 [TBL] [Abstract][Full Text] [Related]
49. Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro. Ilias W; Steinbereithner K J Neural Transm; 1985; 64(3-4):285-93. PubMed ID: 3003253 [TBL] [Abstract][Full Text] [Related]
50. The nature of the presynaptic effects of (+)-tubocurarine at the mouse neuromuscular junction. Ferry CB; Kelly SS J Physiol; 1988 Sep; 403():425-37. PubMed ID: 3253424 [TBL] [Abstract][Full Text] [Related]
51. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents. Cashman JN; Jones RM; Vella LM Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882 [TBL] [Abstract][Full Text] [Related]
52. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Fruergaard K; Viby-Mogensen J; Berg H; el-Mahdy AM Acta Anaesthesiol Scand; 1998 Nov; 42(10):1168-74. PubMed ID: 9834799 [TBL] [Abstract][Full Text] [Related]
53. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat. Wareham AC; Morton RH; Meakin GH Br J Anaesth; 1994 Feb; 72(2):205-9. PubMed ID: 8110574 [TBL] [Abstract][Full Text] [Related]
54. Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report. Geha DG; Blitt CD; Moon BJ Anesth Analg; 1976; 55(3):343-5. PubMed ID: 945014 [TBL] [Abstract][Full Text] [Related]